Key result
Myocarditis associated with COVID-19 infections and mRNA vaccines is a rare complication with a heterogeneous spectrum of clinical manifestations and outcomes.
Why the study?
Four main myocarditis presentations occur in the context of SARS-CoV-2, prompting a review of their clinical features and current management strategies.
This review summarizes the clinical presentations, pathogenesis, and management of four distinct types of SARS-CoV-2-associated myocarditis, highlighting that while rare, they require careful diagnostic evaluation and supportive care.
Answers are grounded in this paper and cite their sources.
Clinicians should maintain awareness of this rare entity; review data leave open optimal risk stratification and long-term management.
There are four main myocarditis presentations identified in the context of severe acute respiratory coronavirus 2 (SARS-CoV-2): myocarditis associated with acute coronavirus disease 2019 (COVID-19) infection, post-acute COVID-19 syndrome, multisystem inflammatory syndrome, and vaccination-associated myocarditis. This article reviews the clinical features and current management strategies for each of these presentations. The overall prevalence of myocarditis is considered to be rare, although accurate estimation is affected by heterogeneity in diagnostic criteria and reporting, as well as infrequent use of gold-standard diagnostic endomyocardial biopsy. Severity of disease can range from mild symptoms to fulminant myocarditis. Therapeutic interventions are typically supportive and extrapolated from treatment for non-COVID-19 viral myocarditis. Several pathogenic mechanisms for the development of myocarditis have been proposed, and ongoing research is critical for elucidating disease pathogenesis and potentially identifying therapeutic targets. The long-term cardiovascular sequelae of SARS-CoV-2 infections and associated myocarditis require further elucidation and understanding.
No takes yet. Share an insight, caveat, or question.
Lovell et al. (2022) conducted a review in COVID-19 and Myocarditis. COVID-19 infection and mRNA vaccines was evaluated. Myocarditis associated with COVID-19 infections and mRNA vaccines is a rare complication with a heterogeneous spectrum of clinical manifestations and outcomes.
Synapse has enriched 10 related papers. Consider them for comparative context: